Whitehawk Therapeutics Inc (WHWK)
Whitehawk Therapeutics Inc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Whitehawk Therapeutics Inc (WHWK) is a Biotechnology company based in US with a market capitalization of $193.4M. Revenue declined 72.5% year-over-year and free cash flow was negative at -$98M. This page tracks WHWK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 40 employees · IPO Aug 1, 2017
Valuation
Valuation & price
$4.70as of May 17, 2026· -7.8% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.42
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$193.4M
Market cap
-72.5%
Revenue growth (YoY)
89.4%
Gross margin
-$98M
Free cash flow (USD)
-$145.7M
Net debt
Net cash position
129.0%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 7, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 12, 2026Filing
Annual Meeting Results
- FinancingMay 29, 2026Filing
Securities Registration
- 8-K eventMay 21, 2026Filing
ADC Pipeline Expansion
- 8-K eventMay 13, 2026Filing
Securities Purchase Agreement
- 8-K eventMay 7, 2026Filing
Earnings Release
- Quarterly reportMay 7, 2026Filing
10-Q Filed
- Insider sellApr 17, 2026Filing
Insider Sell $882KGiacobello Scott M. · CHIEF FINANCIAL OFFICER · $882K
- Insider sellApr 15, 2026Filing
Insider Sell $428KBALL BRYAN · See remarks · $427.9K
- Insider sellApr 13, 2026Filing
Insider Sell $201KBALL BRYAN · See remarks · $201.1K
- Insider sellApr 10, 2026Filing
Insider Sell $49KLennon David James · Director, CHIEF EXECUTIVE OFFICER · $49K
Questions
Frequently asked questions
What is Whitehawk Therapeutics Inc's market cap?
Whitehawk Therapeutics Inc (WHWK) has a market capitalization of $193.4M.
What is WHWK's P/E ratio?
A meaningful P/E ratio is not available for WHWK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is WHWK's price-to-book (P/B) ratio?
WHWK trades at 1.42 times book value per share.
Are insiders buying WHWK stock?
SEC Form 4 filings show no open-market insider buys at Whitehawk Therapeutics Inc in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.